American Well Corporation (AMWL) - What Are Investment Firms Saying About This Stock?

Key Points

• Analysts have a “Hold” consensus on American Well, with five holds, one buy and one sell among seven analysts. The average 12-month price target is $9.50.
• American Well reported a quarterly loss of $0.59 per share, which beat estimates of $0.86, while revenue of $52.05 million exceeded the $49.87 million consensus. Analysts expect a full-year loss of approximately $2.56 per share.
• Insiders sold 19,457 shares worth $248,519 during the latest quarter, while institutional investors own 56.05% of the company; Senvest Management increased its stake by 213.3%.

Shares of American Well Corporation (NYSE:AMWL - Get Free Report) have been assigned an average recommendation of "Hold" from the seven analysts that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and one has given a buy recommendation to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $9.50.

AMWL has been the subject of a number of recent research reports. Weiss Ratings restated a "sell (d-)" rating on shares of American Well in a research report on Thursday, October 15th. Truist Financial set a $12.00 price target on shares of American Well and gave the stock a "hold" rating in a research report on Thursday, August 13th. Needham & Company LLC reissued a "hold" rating on shares of American Well in a research note on Wednesday, August 5th. Finally, Wells Fargo & Company increased their price objective on shares of American Well from $9.00 to $16.00 and gave the company an "overweight" rating in a report on Friday, July 17th.

American Well Stock Down 14.9%

NYSE AMWL opened at $12.75 on Friday. American Well has a 12-month low of $3.71 and a 12-month high of $15.16. The company has a 50 day moving average price of $12.91 and a two-hundred day moving average price of $8.91. The stock has a market capitalization of $211.08 million, a PE ratio of -2.67 and a beta of 1.67.

American Well (NYSE:AMWL - Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported ($0.59) earnings per share for the quarter, beating the consensus estimate of ($0.86) by $0.27. The firm had revenue of $52.05 million during the quarter, compared to the consensus estimate of $49.87 million. American Well had a negative return on equity of 30.12% and a negative net margin of 35.75%. As a group, equities analysts anticipate that American Well will post -2.56 EPS for the current year.

Insider Buying and Selling

In other American Well news, insider Dmitry Zamansky sold 8,442 shares of American Well stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $13.00, for a total value of $109,746.00. Following the sale, the insider directly owned 224,178 shares in the company, valued at approximately $2,914,314. The trade was a 3.63% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Phyllis Gotlib sold 6,677 shares of the company's stock in a transaction dated Thursday, October 1st. The stock was sold at an average price of $13.00, for a total value of $86,801.00. Following the sale, the insider owned 142,504 shares in the company, valued at $1,852,552. The trade was a 4.48% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 19,457 shares of company stock worth $248,519 over the last quarter. 12.84% of the stock is currently owned by corporate insiders.

Institutional Trading of American Well

A hedge fund recently raised its stake in American Well stock. Senvest Management LLC lifted its position in shares of American Well Corporation (NYSE:AMWL - Free Report) by 213.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,136,558 shares of the company's stock after acquiring an additional 773,834 shares during the period. Senvest Management LLC owned approximately 6.87% of American Well worth $5,978,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 56.05% of the company's stock.

About American Well

American Well, doing business as Amwell, is a digital healthcare company that provides technology and services for virtual care. Its platform connects patients with healthcare professionals through video and other digital channels, supporting services such as urgent care, behavioral health, primary care and specialty consultations.

Amwell primarily serves health systems, health plans, employers and other healthcare organizations. Its offerings include the Amwell Converge platform, which is designed to help organizations develop, manage and integrate digital care programs with existing clinical workflows and healthcare systems.

Founded in 2006 by brothers Ido and Roy Schoenberg, the company was formerly known as American Well and adopted the Amwell brand in 2020.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.